Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Extent of High-Grade Prostatic Adenocarcinoma in Multiparametric Magnetic Resonance Imaging-Targeted Biopsy Enhances Prediction of Pathologic Stage.

Archives of pathology & laboratory medicine·2021

Same author

The Importance of Tumor Length in Needle Biopsies of the Prostate.

American journal of clinical pathology·2020

Same author

Initial Screening for Cervical Intraepithelial Neoplasia.

American journal of clinical pathology·2019

Same author

The Calculus of Serum PSA.

American journal of clinical pathology·2019

Same author

A review of the incidence of adenocarcinoma detected during surveillance for Barrett's esophagus.

Human pathology·2018

Same author

Serum Prostate-Specific Antigen (PSA) Concentration, PSA Mass, and Obesity: A Mathematical Analysis.

American journal of clinical pathology·2018

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Tumor length in prostate cancer.

Robin T Vollmer¹

¹Laboratory Medicine, Veterans Affairs Medical Center, Durham, NC 27705, USA.

American Journal of Clinical Pathology

|June 14, 2008

Summary

Tumor length is a key predictor of overall survival in prostate cancer patients, especially for those with larger tumors. Measuring tumor length may be unnecessary for routine cases but valuable for specific patient subsets and research.

Area of Science:

Oncology
Urology
Pathology

Background:

Prostate cancer prognosis relies on various factors.
Accurate prognostic indicators are crucial for patient management and research.

Purpose of the Study:

To assess the prognostic significance of tumor length and fraction of positive biopsy cores on overall survival in prostate cancer.
To determine the clinical utility of tumor length measurement in routine prostate cancer assessment.

Main Methods:

Retrospective analysis of data from 526 prostate cancer patients.
Cox proportional hazards model including age, PSA, grade, and fraction of positive cores.
Median follow-up exceeding 6 years.

Main Results:

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Experiment Videos

Last Updated: Jul 4, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Tumor length demonstrated the strongest association with overall survival (P=6 x 10(-5)).
This association was most pronounced in patients with tumors exceeding 20 mm.
Tumor length, age, PSA, Gleason score, and fraction of positive cores were interdependent.

Conclusions:

Tumor length measurement may not be essential for routine prostate cancer cases.
Tumor length can be a valuable prognostic variable in clinical trials and for identifying high-risk patients.
It offers a concise indicator of adverse outcomes, particularly when other variables appear less ominous.